Skip to main content
OpenTrials

Clinical trial condition

Respiratory Tract Neoplasms

Explore clinical trials studying Respiratory Tract Neoplasms. Study availability and eligibility vary by location and protocol.

8,077 public trials 1,842 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Tract Neoplasms trial results

Active, Not Recruiting

A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer

NCT06012435

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Alaska Oncology and Hematology, LLC Anchorage, Alaska, United States
  • Providence Medical Foundation Fullerton, California, United States
  • Providence St. Jude Medical Center Virginia K. Crosson Cancer Center and Infusion Center Fullerton, California, United States
  • Providence St. Jude Medical Center Fullerton, California, United States
View all 331 locations
View Trial Details
Active, Not Recruiting

Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment

NCT06151574

Conditions
Lung Cancer, Non-squamous, Non-small Cell, Lung Diseases, Lung Neoplasms, +5 more
Locations
  • Clearview Cancer Institute Huntsville, Alabama, United States
  • Pioneer Research Center - Bullhead City Bullhead City, Arizona, United States
  • Precision NextGen Oncology Beverly Hills, California, United States
  • ClinRé 001-022 (Premier Cancer Care and Infusion Center) Fresno, California, United States
View all 163 locations
View Trial Details
Active, Not Recruiting

Phase 1/2 Study of Silevertinib (BDTX-1535) in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations

NCT05256290

Conditions
Advanced Lung Carcinoma, Advanced Non-Small Cell Squamous Lung Cancer, Brain Diseases, +23 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • City of Hope Huntington Beach Huntington Beach, California, United States
  • City of Hope Orange County Lennar Foundation Cancer Center Irvine, California, United States
View all 25 locations
View Trial Details
Active, Not Recruiting

DAREON™-9: A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With Small Cell Lung Cancer When Taken Together With a Single Agent Chemotherapy

NCT05990738

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • Mayo Clinic - Florida Jacksonville, Florida, United States
  • University of Miami Miami, Florida, United States
  • Virginia Commonwealth University Richmond, Virginia, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

Plasma-Adapted First-Line Pembro In NSCLC

NCT04166487

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Boston Medical Center Boston, Massachusetts, United States
  • Dana-Farber at Steward St. Elizabeth's Medical Center Brighton, Massachusetts, United States
View Trial Details
Active, Not Recruiting

A Phase 2 Study of Tarlatamab in Patients With Small Cell Lung Cancer (SCLC)

NCT05060016

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Christiana Care Health Services Newark, Delaware, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 80 locations
View Trial Details
Active, Not Recruiting

Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors

NCT03485209

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +28 more
Locations
  • UCSD Medical Center - Encinitas Encinitas, California, United States
  • UC San Diego Medical Center - La Jolla (Jacobs Medical Center / Thornton Pavilion) La Jolla, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • UCSD Koman Family Outpatient Pavilion La Jolla, California, United States
View all 175 locations
View Trial Details
Active, Not Recruiting

Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin

NCT02414269

Conditions
Adenoma, Breast Cancer, Breast Diseases, +21 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Consent and Follow-Up) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Consent and Follow-Up) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Consent and Follow-Up) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack (Consent and Follow-Up) Commack, New York, United States
View Trial Details
Active, Not Recruiting

A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.

NCT06447662

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +29 more
Locations
  • Highlands Oncology Group, PA Fayetteville, Arkansas, United States
  • Highlands Oncology Group, PA Rogers, Arkansas, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
  • City of Hope (City of Hope National Medical Center, City of Hope Medical Center) Duarte, California, United States
View all 27 locations
View Trial Details

Related conditions